Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q2 2026 Earnings

30AprConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.95

-0.87

-0.79

-0.71

Details

Expected EPS

-0.880522

Actual EPS

-0.71

Surprise EPS

0.17

Surprise Percent

+19.37%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.71 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.